Please assess the completion status of the following clinical trial:

Trial Title: Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Gastric cancer patients with laparoscopic subtotal gastrectomy~* 19-75 years~* Body mass index(BMI) \> 25kg/m2~* American Society of Anesthesiologists I-III~Exclusion Criteria:~* American Society of Anesthesiologists Class IV~* End stage renal disease (ESRD) patient~* Patients with allergy to muscle relaxants~* Patients with diseases that may affect muscle relaxation

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Deep neuromuscular block group (Type: EXPERIMENTAL): Sugammadex sodium 4mg/kg/IV after operation
- Moderate neuromuscular group (Type: EXPERIMENTAL): Sugammadex sodium 2mg/kg/IV after operation

Based on this trial design, predict the completion outcome and termination type (if applicable).